Rchr
J-GLOBAL ID：201801012167870879   Update date: Jan. 30, 2024

Ohsawa Yutaka

オオサワ ユタカ | Ohsawa Yutaka
Affiliation and department：
Kawasaki Medical School

About Kawasaki Medical School


Research field  (1)： Neurology
Research theme for competitive and other funds  (15)：
  • 2021 - 2024 Elucidation of molecular pathogenesis of TTR amyloid neuropathy
  • 2020 - 2023 nNOS活性化による筋ジストロフィー疾患修飾効果の検討
  • 2017 - 2020 Therapeutic study of sarcopenia by TGF-beta inhibition strategy
  • 2016 - 2019 Schwann cell abnormality due to variant TTR and neurodegeneration
  • 2015 - 2018 Regulation of caveolin-3 on pathomechanisms leading to muscular dystrophies
Show all
Papers (61)：
  • Yutaka Ohsawa, Hideaki Ohtsubo, Asami Munekane, Kohei Ohkubo, Tatsufumi Murakami, Masahiro Fujino, Shin-Ichiro Nishimatsu, Hiroki Hagiwara, Hirotake Nishimura, Ryuki Kaneko, et al. Circulating α-Klotho Counteracts Transforming Growth Factor-β-Induced Sarcopenia. The American journal of pathology. 2023. 193. 5. 591-607
  • Keiro Shirotani, Kaori Watanabe, Daisuke Hatta, Yumiko Kutoku, Yutaka Ohsawa, Yoshihide Sunada, Takayuki Kondo, Haruhisa Inoue, Nobuhisa Iwata. Alterations of ATG4A and LC3B in neurons derived from Alzheimer's disease patients. Genes to cells : devoted to molecular & cellular mechanisms. 2023. 28. 4. 319-325
  • Yutaka Ohsawa, Hideaki Ohtsubo, Yoshihiko Saito, Shinichiro Nishimatsu, Hiroki Hagiwara, Tatsufumi Murakami, Ichizo Nishino, Yoshihide Sunada. Caveolin 3 suppresses phosphorylation-dependent activation of sarcolemmal nNOS. Biochemical and Biophysical Research Communications. 2022
  • Asami Munekane, Yutaka Ohsawa, Mariko Okubo, Taiji Nagai, Hirotake Nishimura, Ichizo Nishino, Yoshihide Sunada. Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy. Internal Medicine. 2022
  • Asami Munekane, Yutaka Ohsawa, Tokiko Fukuda, Hirotake Nishimura, Shin-ichiro Nishimatsu, Hideo Sugie, Yoshihiko Saito, Ichizo Nishino, Yoshihide Sunada. Maximal Multistage Shuttle Run Test-induced Myalgia in a Patient with Muscle Phosphorylase B Kinase Deficiency. Internal Medicine. 2022. 61. 8. 1241-1245
ｍore...
MISC (205)：
ｍore...
Lectures and oral presentations  (3)：
  • The inhibitory core of the myostatin prodomain has potential to treat muscle atrophy
    (2018)
  • マイオスタチン阻害ペプチドによる筋ジストロフィー治療の基盤研究
    (第35回日本神経治療学会総会 2017)
  • マイオスタチン阻害ペプチドによる筋ジストロフィーとサルコペニア治療法の開発
    (第3回日本筋学会学術集会 2017)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM